| Discharge Regimen | Year of Transplant | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Total | Patients | 3,423 | 3,619 | 3,748 | 4,060 | 4,435 | 4,884 | 5,022 | 5,318 | 5,268 | 5,162 |
| Steroids Avoided | 243 | 294 | 369 | 405 | 771 | 956 | 1,062 | 1,150 | 1,272 | 1,032 | |
| Rate | 7.1% | 8.1% | 9.8% | 10.0% | 17.4% | 19.6% | 21.1% | 21.6% | 24.1% | 20.0% | |
| CyA | Patients | 372 | 226 | 117 | 97 | 76 | 58 | 65 | 34 | 43 | 37 |
| Steroids Avoided | 36 | 6 | 18 | 11 | 20 | 10 | 12 | 6 | 5 | 10 | |
| Rate | 9.7% | 2.7% | 15.4% | 11.3% | 26.3% | 17.2% | 18.5% | 17.6% | 11.6% | 27.0% | |
| Tac | Patients | 1,381 | 1,194 | 1,338 | 1,646 | 1,639 | 1,760 | 1,691 | 1,369 | 1,225 | 1,001 |
| Steroids Avoided | 80 | 52 | 129 | 195 | 331 | 485 | 504 | 282 | 246 | 196 | |
| Rate | 5.8% | 4.4% | 9.6% | 11.8% | 20.2% | 27.6% | 29.8% | 20.6% | 20.1% | 19.6% | |
| CyA+MMF | Patients | 315 | 258 | 212 | 186 | 179 | 194 | 188 | 218 | 227 | 232 |
| Steroids Avoided | 9 | 11 | 7 | 8 | 19 | 40 | 28 | 52 | 69 | 48 | |
| Rate | 2.9% | 4.3% | 3.3% | 4.3% | 10.6% | 20.6% | 14.9% | 23.9% | 30.4% | 20.7% | |
| Tac+MMF | Patients | 882 | 1,204 | 1,433 | 1,595 | 2,050 | 2,334 | 2,703 | 3,292 | 3,432 | 3,547 |
| Steroids Avoided | 56 | 95 | 107 | 124 | 284 | 303 | 433 | 687 | 827 | 708 | |
| Rate | 6.3% | 7.9% | 7.5% | 7.8% | 13.9% | 13.0% | 16.0% | 20.9% | 24.1% | 20.0% | |
| CyA+Aza | Patients | 147 | 109 | 51 | 56 | 24 | 52 | 12 | 5 | 4 | 6 |
| Steroids Avoided | 12 | 1 | 0 | 6 | 22 | 26 | 0 | 0 | 0 | 0 | |
| Rate | 8.2% | 0.9% | 0.0% | 10.7% | 91.7% | 50.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Tac+Aza | Patients | 100 | 76 | 65 | 88 | 100 | 47 | 21 | 11 | 19 | 6 |
| Steroids Avoided | 5 | 3 | 4 | 2 | 13 | 19 | 17 | 5 | 9 | 0 | |
| Rate | 5.0% | 3.9% | 6.2% | 2.3% | 13.0% | 40.4% | 81.0% | 45.5% | 47.4% | 0.0% | |
| CyA+Siro | Patients | 3 | 36 | 25 | 25 | 23 | 23 | 31 | 42 | 34 | 28 |
| Steroids Avoided | 0 | 23 | 16 | 1 | 0 | 2 | 13 | 39 | 31 | 17 | |
| Rate | 0.0% | 63.9% | 64.0% | 4.0% | 0.0% | 8.7% | 41.9% | 92.9% | 91.2% | 60.7% | |
| Tac+Siro | Patients | 4 | 194 | 197 | 107 | 54 | 85 | 50 | 65 | 22 | 21 |
| Steroids Avoided | 0 | 34 | 33 | 15 | 8 | 22 | 5 | 10 | 5 | 7 | |
| Rate | 0.0% | 17.5% | 16.8% | 14.0% | 14.8% | 25.9% | 10.0% | 15.4% | 22.7% | 33.3% | |
| Siro+MMF | Patients | 2 | 28 | 48 | 46 | 43 | 42 | 45 | 43 | 34 | 37 |
| Steroids Avoided | 0 | 1 | 0 | 3 | 8 | 5 | 6 | 12 | 9 | 15 | |
| Rate | 0.0% | 3.6% | 0.0% | 6.5% | 18.6% | 11.9% | 13.3% | 27.9% | 26.5% | 40.5% | |
| Other Regimen | Patients | 217 | 294 | 262 | 214 | 247 | 289 | 216 | 239 | 228 | 247 |
| Steroids Avoided | 45 | 68 | 55 | 40 | 66 | 44 | 44 | 57 | 71 | 31 | |
| Rate | 20.7% | 23.1% | 21.0% | 18.7% | 26.7% | 15.2% | 20.4% | 23.8% | 31.1% | 12.6% | |